MDM2 and gastric cancer: In summary, this meta-analysis provided evidence of the association between MDM2 SNP309 polymorphism and gastric cancer risk, supporting the hypothesis that the SNP309 polymorphism may be a low-penetrance susceptibility marker of gastric cancer.